Case Report
Accepted on 12 Aug 2025
Pembrolizumab and Enfortumab Vedotin in Plasmacytoid Urothelial Carcinoma: A Case Series
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1608291
Type at least 3 characters
1,704 articles
Original Research
Accepted on 11 Aug 2025
A novel prognostic biomarker DUSP6 promote the malignant progression of bladder cancer through mTOR mediated mitophagy
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1603069
Original Research
Accepted on 11 Aug 2025
Multimodal Prognostic Models for Bladder Urothelial Carcinoma: Uroplakin III Combined with Serum and Demographic Data
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1636358
Case Report
Published on 11 Aug 2025
Synchronous papillary renal neoplasm with reverse polarity and multilocular cystic renal neoplasm of low malignant potential in unilateral kidney: case report with molecular analysis and literature review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1605192
- 146 views
Case Report
Published on 11 Aug 2025
Significant response to toripalimab plus axitinib for metastatic chromophobe renal cell carcinoma with sarcomatoid differentiation: a case report and literature review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1606414
- 546 views
Case Report
Accepted on 08 Aug 2025
Case Report: Complete Response to Preoperative Ipilimumab and Nivolumab Combination Therapy in Advanced Papillary Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus and Multiple Metastases
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1547387
- 490 views
Correction
Accepted on 08 Aug 2025
Correction: MED10 Drives the Oncogenicity and Refractory Phenotype of Bladder Urothelial Carcinoma Through the Upregulation of hsa-miR-590
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1667245
- 143 views
Systematic Review
Accepted on 08 Aug 2025
A network meta-analysis of the safety of systemic treatments in patients with metastatic hormone-sensitive prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1468928
- 101 views
Systematic Review
Published on 08 Aug 2025
Meta-analysis on the safety and efficacy of Erdafitinib in treating FGFR1–4 mutated solid tumors
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1571434
- 304 views
Case Report
Published on 07 Aug 2025
Case Report: Complete response with combination oncolytic virus immunotherapy in a patient with stage IV renal cell carcinoma—a promising innovative approach
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1631155
- 497 views
Original Research
Accepted on 06 Aug 2025
Biparametric MRI-based Radiomics for Differentiating Clinically Significant Prostate Cancer Among Prostate-specific Antigen Level of Gray Zone
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1615005
Systematic Review
Published on 06 Aug 2025
Comparative efficacy of holmium laser versus plasma techniques in the surgical management of non-muscle invasive bladder cancer: a meta-analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1625901
- 315 views
Original Research
Published on 06 Aug 2025
A multi-data fusion deep learning model for prognostic prediction in upper tract urothelial carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1644250
- 379 views
Case Report
Accepted on 05 Aug 2025
Scrotal hemangioma: A case report and systematic literature review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1586677
Original Research
Published on 05 Aug 2025
Overexpression of BNIP3 in renal carcinoma cells can promote apoptosis of renal carcinoma cells through HIF-1α-BNIP3-mediated autophagy
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1614378
- 365 views
Original Research
Published on 04 Aug 2025
Relationship between immunohistochemical markers and clinical pathological variables in clear cell renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1580024
- 464 views